Marrubium vulgare / Malrove

J Ethnopharmacol  2006 Dec 6;108(3):379-84. doi: 10.1016/j.jep.2006.05.023. Epub 2006 Jun 2.

Antioedematogenic effect of marrubiin obtained from Marrubium vulgare. Hellen K Stulzer 1, Monika P Tagliari, Julio A Zampirolo, Valdir Cechinel-Filho, Valfredo Schlemper

This paper describes the antioedematogenic profile of marrubiin (1), the main constituent of Marrubium vulgare, a medicinal plant used in folk medicine of several countries to treat different pathologies. Compound (1) was analyzed in a model of microvascular leakage in mice ears. The results show that it exhibits significant and dose-related antioedematogenic effects. The results obtained for ID50 values (mg/kg, i.p.) and maximal inhibition (%) for the different phlogistic agents used were as follows: histamine (HIS, 13.84 mg/kg and 73.7%); (BK, 18.82 mg/kg and 70.0%); carrageenan (CAR, 13.61 mg/kg and 63.0%). The other phlogistic agonists, such as prostaglandin E2 (PGE2), caused inhibition of less than 50%. In addition, (1) (100 mg/kg) significantly inhibited the OVO-induced allergic edema in actively sensitized animals (maximal inhibition 67.6+/-4%). Our results demonstrate that the systemic administration of marrubiin exerts a non-specific inhibitory effect on pro-inflammatory agent-induced microvascular extravasation of Evans blue in mouse ear.

Planta Med. 2003 Jan;69(1):75-7. doi: 10.1055/s-2003-37042.

The vasorelaxant activity of marrubenol and marrubiin from Marrubium vulgare. Sanae El Bardai, Nicole Morel, Maurice Wibo, Nicolas Fabre, Gabriel Llabres, Badiaa Lyoussi, Joëlle Quetin-Leclercq

PMID: 12567286 DOI: 10.1055/s-2003-37042

Crude extracts of the aerial parts of Marrubium vulgare show a potent in vitro inhibition of KCl-induced contraction of rat aorta. Bio-guided fractionations, spectroscopic analysis and chemical derivatization revealed the furanic labdane diterpenes marrubenol and marrubiin as the most active compounds.

Review Molecules. 2020 Jun 24;25(12):2898. doi: 10.3390/molecules25122898.

Marrubium vulgare L.: A Phytochemical and Pharmacological Overview

Milica Aćimović 1, Katarina Jeremić 2, Nebojša Salaj 2, Neda Gavarić 2, Biljana Kiprovski 1, Vladimir Sikora 1, Tijana Zeremski 1

Marrubium vulgare is a plant with high bioactive potential. It contains marrubiin, a labdane diterpene that is characteristic for this genus, as well as a complex mixture of phenolic compounds. According to numerous studies, M. vulgare acts as a good antioxidant agent, and due to this, it could potentially be useful in treatments of cancer, diabetes mellitus, and liver diseases. In addition, its anti-inflammatory, wound-healing, antihypertensive, hypolipidemic, and sedative potential are discussed. Apart from that, its antimicrobial activity, especially against Gram+ bacteria, fungi, herpes simplex virus, and parasites such as Toxoplasma gondii, Trichomonas vaginalis, and Plasmodium berghei-berghei was recorded. Additionally, it could be used as a chicken lice repellent, herbicide, and natural insecticide against mosquito larvae and natural molluscicide. In veterinary medicine, M. vulgare can be used as an anthelmintic against the eggs and larvae of bovine strongyles parasites, and as an antibiotic against bovine mastitis caused by resistant bacterial strains. Due to the mentioned benefits, there is a tendency for the cultivation of M. vulgare in order to ensure high-quality raw material, but more firm scientific evidence and well-designed clinical trials are necessary for the well-established use of M. vulgare herb and its preparations.

Marrubium vulgare / Applications in Medicine and as Pesticides

Marrubium vulgare herb tea is used as a cough suppressant, and expel catarrh. ‘Materia Medica Vegetabilis’ gave directions for the preparation of M. vulgare decoction with honey against bronchitis and coughs [56]. The herb is used to prepare the well-known horehound candy, which, due to its pleasant taste is used to relieve cough, hoarseness, and bronchitis. It is generally recognized as safe in the USA, and it is widely used as a flavoring agent. In modern phytotherapy, various M. vulgare herbal medicinal products are used as an expectorant in cough associated with cold, for symptomatic treatment of mild dyspeptic complaints, such as bloating flatulence, and in temporary loss of appetite [2,57]. M. vulgare has a bitter value of 3.0, acting as the bitter gustative receptores (on the base of the tongue) stimulator. This effect leads to the increase in gastric and biliar secretion and the stimulation of appetite [58]. M. vulgare is one of the most popular herbal pectoral remedies in traditional medicine, and it is used as a bitter tonic, expectorant, and diuretic [3]. In addition to widespread use in the treatment of respiratory disorders, it has been reported that the folk use of M. vulgare includes treatment for jaundice, painful menstruation, and as a laxative in higher doses [59,60]. Externally, it is used for skin damage, ulcers, and wounds [23]. The importance of this plant in traditional medicine is evidenced by a number of pharmacopoeias and standard text books with monographs of M. vulgare [2,61]. Literature data suggest that Marrubii herba is traditionally used in a number of countries outside Europe [34]. Generally, its characteristic and most common use in all folk medicines is for the treatment of respiratory and gastrointestinal disorders. However, in Tunisian traditional use, this plant was also used as an hypotensive, hypoglycemic, and cardiotonic agent [62].

M. vulgare can be applied as herbal tea for oral use (single dose: 1–2 g of herbal material in 250 mL of boiling water, as a herbal infusion, 3 times a day; daily: dose 3–6 g), powdered herbal substance (single dose: 225–450 mg, 3 times a day; daily dose: 675–1350 mg), expressed juice (single dose: 10–20 mL, 3 times a day; daily dose: 30–60 mL) and liquid extract (single dose: 1.5–4.0 mL, 3 times a day; daily dose: 4.5–12 mL). The use in children under 12 years of age is not recommended. Safety during pregnancy and lactation has not been established [2]. However, results showed that a group of normal rats treated with the ethanol–water extract of M. vulgare (80:20, v/v) and pregnant rats treated with the extract exhibited a significant decrease in hematological parameters: red blood cells, hematocrit, hemoglobin, and mean corpuscular volume. The extract of M. vulgare caused a significant decrease on the mean implantations of fetuses and their size. As for the macroscopic and histological appearance of uterus; these data showed no change in normal treated rats. Contrary to these, the treated pregnant rats showed a severe histological change characterized by interrupted gestation, as well as the lysing of placental and embryo tissue in the uterus. All these results support the hypothesis of an abortifacient effect of M. vulgare [63]. Possibly, the furanic labdane diterpene marrubin and premarrubin could be responsible for these effects, since they are structural analogues with leosibiricin, an active diterpene of Leonorus cardiaca, which is a plant that is known for its emenagogue activity and contraindicated in pregnancy [19]. Additionally, the effects of alcoholic extract of Marrubum vulgare on hormonal parameters in a female rat model (receiving 500 mg/kg and 1000 mg/kg of M. vulgare extract for 21 days) of polycystic ovarian syndrome were studied. Luteinizing hormone (LH) hormone significantly decreased at a dose of 1000 mg/kg, and estradiol and progesterone decreased at doses of 500 mg/kg and 1000 mg/kg, while testosterone decreased at a dose of 1000 mg/kg. These findings contribute to the potential influence of examined extract on female hormones, thus questioning their safe usage in pregnancy [64]. In addition, M. vulgare is mentioned in certain literature as a potentially nephrotoxic plant [65]. However, there is no relevant scientific evidence to confirm these claims.

In recent years, numerous pharmacological effects of M. vulgare extracts have been studied. As a good antioxidant agent, M. vulgare proved to be very useful in treatments of cancer, diabetes mellitus, and liver diseases. In addition, many studies indicated that this plant possesses anti-inflammatory and hemostatic effects, as well as antihypertensive, sedative potential, and antimicrobial properties.

5.1. Antioxidant Activity

The imbalance in homeostatic processes between oxidants and antioxidants in the body, which is caused by free radicals, leads to oxidative stress. Oxidative stress is considered to be the primary cause of aging and a wide variety of human diseases, such as cancers, diabetes, neurodegenerative disorders, rheumatoid arthritis, etc. Antioxidants are substances that significantly delay, prevent, or inhibit oxidative damage to target molecules [66].

The in vitro antioxidant properties of M. vulgare methanol extracts were determined using DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging assay and the results revealed a strong activity with the half maximal inhibitory concentration (IC50) value of 8.24–12.42 μg/mL [25,31]. The antioxidant activity investigated by the same method shows that M. vulgare essential oil exhibits IC50 value of 153.84 μg/mL, which is about two times higher than a synthetic antioxidant (butylated hydroxytoluene or BHT) [67]. Photochemiluminescence (PLC) assay, evaluating the antioxidant activity of the compound in the presence of superoxide anion radical, reactive oxygen species (ROS) also generated in the human body, determined the strong antioxidant effect of methanol and acetone M. vulgare extracts (261.41 and 272.90 μmol TE/g respectively), while the lower activity was observed when essential oil and isolated marrubin were investigated [68]. Djeridane et al. [69] determined that there is a good correlation of antioxidant potential and the content of phenolic compounds. Furthermore, acetone extracts, deodorized acetone extracts, and deodorized water extracts from M. vulgare leaves were tested for their antioxidant activity in rapeseed oil at 80 °C. The effect of the extracts on the edible oil stability was assessed by measuring weight gain, peroxide value, and UV absorption [70]. Acetone extracts showed better antioxidant properties than deodorized acetone extracts. According to Yousefi et al. [25], the high antioxidant activity of M. vulgare was associated with the presence of marrubiin, along with phenolics and flavonoids exerting a synergistic effect.

In addition, M. vulgare methanolic extracts showed a dose-dependent ferric reducing capacity (Ferric Reducing Antioxidant Power Assay, or FRAP) with a value equal to 50.01 μg AAE/g of extract when compared to ascorbic acid (AAE: Ascorbic Acid Equivalents) [31]. Other authors [15,28] reported that FRAP assay of ethanol–water extract of M. vulgare (70:30, v/v) showed IC50 of 64.07 mg AAE/g of dry extract and IC50 for the neutralization of DPPH, hydroxyl (OH), and nitroso (NO) radicals were 13.41, 63.99, and 64.86 μg/mL, respectively. Furthermore, inhibition on lipid peroxidation was examined in vitro [28], the results indicating the antiatherogenic potential of M. vulgare extracts.

Bouterfas et al. 2016 [71] also determined the potent activity of M. vulgare extracts on DPPH radical but concluded that this effect varied significantly depending on the type of the organic solvent used for extraction and sampling location.

Lastly, all these finding indicate the antiradical potential of M. vulgare extracts using different in vitro tests, but research should be directed toward in vivo experiments in order to elucidate their full antioxidant capacity.

5.2. Hepatoprotective Properties

Investigation of the hepatoprotective and therapeutic effect of ethanol–water extract (70:30, v/v) and petroleum ether extracts on CCl4-induced liver cell toxicity in mice showed that liver and kidney function parameters remained in the normal levels in groups treated with M. vulgare extracts. The administration of M. vulgare ethanolic extracts significantly enhanced SOD (superoxide dismutase) and CAT (catalase) activity, as well as total antioxidant capacity, with significant reduction in lipid peroxide concentration when extracts were used as protective or therapeutic agents [72]. The antihepatoxic activity of ethanol–water extracts (80:20, v/v) of M. vulgare in different concentrations (100, 200, 300, and 400 mg/kg) was assessed by measuring lipid profile parameters such as AST (aspartate aminotransferase), ALT (alanine aminotransferase), ALP (alkaline phosphatase), GSH (reduced gluthation), SOD, and malondialdehyde (MDA), as well as by histopathological examination of CCl4-induced liver damage in rats. Different concentrations of extracts showed a significant antihepatotoxic effect by reducing the levels of AST and ALT significantly, whereas the ALP level was insignificantly decreased. Regarding the antioxidant activity, these extracts exhibited a significant decrease in SOD and contents of GSH and MDA (a biomarker of membrane lipids peroxidation). These findings showed that different concentrations of M. vulgare extract protect liver against CCl4-induced hepatotoxicity, and the effect may be attributed to its antioxidant activity [73].

Methanol extracts of M. vulgare showed considerable antihepatotoxic effect by significantly reducing levels of AST, ALT, and LDH. However, the decrease in ALP levels was not significant. As for the antioxidant activity, M. vulgare extracts notably increased the GPx (glutathione peroxidases), GR (glutathione reductase), and GST (glutathione transferase) activities in rat liver tissue. In addition, it increased the GSH content and decreased the production of MDA level, adding to alleviated histopathological changes in rats’ livers treated with CCl4 [74].

In another animal study, marrubic acid exhibited a significant antihepatotoxic activity by reducing the elevated levels of serum enzymes such as serum glutamate oxaloacetate transaminase (SGOT) by 40.16%, serum glutamate pyruvate oxaloacetate transaminase (SGPT) by 35.06%, and alkaline phosphatase (ALP) by 30.51% [16].

The hepatoprotective potential of 12 pure compounds (marrubiin, premarrubiin, vulgarin, luteol, vulgarol, apigenin-7-glucronide, vitexin, apigenin, chryseriol, stachydrine, acetoside, and 1-caffeory-L-malic acid) characteristic for M. vulgare were tested on CCl4-induced acute liver injury in rats through the in silico method. All compounds showed expected and similar bioactivity, especially when it comes to liver-associated enzymes inhibition [17].

5.3. Antiproliferative Activity

M. vulgare are often used traditionally in cancer treatment [75,76], but the exact mechanisms of action and scientific validity of their usage are yet to be discovered.

Zarai et al. [77] reported the ability of M. vulgare essential oil to inhibit the proliferation of cervical cancer (HeLa) cell lines with an IC50 value of 0.258 μg/mL. M. vulgare ethanol–water extracts (70:30, v/v) reduced the viability of melanoma (B16) and glioma (U251) in a dose-dependent manner. By demonstrating the ability of M. vulgare extracts to inhibit proliferation, induce apoptosis, and cytoprotective autophagy, the results suggested that this plant could be a good candidate for anti-melanoma and anti-glioma therapy [22]. In addition, the methanolic extract of M. vulgare was evaluated for its in vitro cytotoxic activity by measuring the percentage of viable cells’ glioblastoma multiforme cell lines (U87, LN229 and T98G) using a luminescence system. After evaluating the cytotoxicity impact that M. vulgare has on U87 (IC50: 270.3 μM), LN229 (IC50: 343 μM), and T98G (IC50: 336.6 μM) from glioblastoma multiforme cell lines, it was concluded that it is the most efficient in two cell lines, U87 (69.9%) and LN229 (71%) [30].

The in vitro anticancer activity of M. vulgare ethanol–water extracts (90:10, v/v) and six pure compounds (acacetin, acacetin-7-rhamnoseide, apigenin, diosmetin, diosmetin-7-glucoside, and luteolin-7-rhamnoside) were also tested against Ehrlich tumor cell lines, human tumor cell lines U251 (brain tumor) and MCF7 (breast cell lines) [43]. Alcoholic extracts, acacetin, apigenin, and acacetin-7-rhamnoside showed high anticancer activity against breast carcinoma, whereas all tested compounds had anticancer activity against Ehrlich tumor cell lines. Another study [45] showed that labdanein (methoxylated flavone) from M. vulgare displayed a moderate effect on human myeloid leukemia (K562) and imatinib-resistant human myeloid leukemia (K562R) cells, as well as on human B cell precursor leukemia cell lines (697). The authors of this study suggested that these results provide a common natural source for the hemi-synthesis of future ladanein-derived flavones and the study of their antileukemic activity. Tlili et al. [78] examine the effect of M. vulgare and other Tunisian plant extracts on leukemia and colon cancer cell lines (K-562 and CaCo-2, respectively). Subsequently, the anti-inflammatory activity was assessed, and the results showed that white horehound possesses the highest activity in the group of analyzed plants.

Kozyra et al. [79] investigated the potential anticancer activity of methanolic extracts phenolic acid (PhA) fractions of M. vulgare against a human melanoma cancer cell line (A375) and normal human skin fibroblasts (BJ) using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide test, cell cycle analysis, and real-time monitoring of cell viability. Surprisingly, examined fractions demonstrated a low total phenolic content and did not show significant antioxidative properties, but the nonhydrolyzed PhA fraction exhibited cytotoxic activity against a human melanoma cancer cell line, without affecting normal fibroblasts. Both acidic and alkaline hydrolysis abolished this activity, indicating that the esterified forms of phenolic compounds exhibit the observed cytotoxic effects. Since M. vulgare is abundant in phenylpropanoid (cinnamic) esters and phenylethanoid glycosides, further investigation of these compounds may provide an insight into the exact anticancer mechanism of action and use as a model for cancer treatment drug development.

Moreover, Shawky [80] used the network pharmacology approach to identify the main active constituents of North African plants against cancer molecular targets and to explore their therapeutic mechanism. M. vulgare possessed the largest number of plant–constituent–target gene interactions indicating cell cycle arrest and apoptosis in addition to the inhibition of cellular proliferation as possible mechanisms and marked this plant as a potential source for the supportive treatment of cancer.

5.4. Anti-Inflammatory Activity

Investigation of the anti-inflammatory effect of the methanolic extracts of M. vulgare on isoproterenol-induced myocardial infarction in a rat model showed that serum creatinine kinase-MB was subsided by 52.2–69.0% (depending on the dose of M. vulgare extract). In addition, the treatment with extracts significantly reduced myocardial myeloperoxidase activity in myocardial infarction [81,82]. Levels of tumor necrosis factor alpha (TNF-α) also declined considerably in the serums of rats with myocardial infarction. In addition, peripheral neutrophil count was significantly lowered by all doses of the extract. Interstitial fibrosis was significantly attenuated by treatment with M. vulgare compared to control. The results of this study demonstrated that M. vulgare extracts have strong protective effects against isoproterenol-induced myocardial infarction, and it seems possible that this protection is a result of its anti-inflammatory properties. Furthermore, the 11-oxomarrubiin, vulgarcoside A, and 3-hydroxyapigenin-4′-O-(6′′-O-p-coumaroyl)-β-d-glucopyranoside from the methanolic extract of M. vulgare exhibited moderate to low levels of inhibition on NO production, while vulgarcoside A also showed a moderate inhibition effect on pro-inflammatory cytokinine TNF-α [20]. Glycosidic phenylpropanoid esters from M. vulgare showed inhibitory activity toward the cyclooxygenase (COX) enzyme, which plays a key role in the transformation of arachidonic acid into pro-inflammatory prostaglandins and is associated with inflammation [40].

The assessment of anti-inflammatory activity showed that the oral administration of methanolic extract of M. vulgare at a dose of 200 mg/kg in rats treated with carrageenin causes a significant decrease (87.30%) of inflammation compared to standard positive control (diclofenac), which showed 85.52% protection in this test [31]. In a model of microvascular leakage in mice ears, the analysis shows that marrubiin from M. vulgare exhibits significant and dose-related antioedematogenic effects. The treatment of mice with marrubiin caused a dose-dependent inhibition of carregeenan, bradykinin, and histamine-induced extravasation of Evans blue in mice ears, with maximal inhibitions of 63.0%, 70.0%, and 73.7%, respectively. The other phlogistic agonists, such as prostaglandin E2, caused an inhibition of less than 50%. In addition, marrubiin significantly inhibited the ovalbumin-induced allergic edema in actively sensitized animals. These results demonstrate that the systemic administration of marrubiin exerts a non-specific inhibitory effect on pro-inflammatory agent-induced microvascular extravasation of Evans blue in mice ears [36]. The evaluation of anti-inflammatory activities against inflammation induced by carrageenen and prostaglandin E2 and analgesic activity in the p-benzoquinone-induced abdominal constriction test showed that methanolic extracts of M. vulgare have a similar effect as reference drugs indomethacin and acetylsalicylic acid [59].

An in vitro investigation of the anti-inflammatory effect that six compounds from M. vulgare (luteolin-7-O-β-glucopyranoside, apigenin-7-O-β-glucopyranoside, oleanolic acid, β-sitosterol, luteolin-7-O-rutinoside, and rosmarinic acid) have on COX showed that these compounds inhibited the formation of hormones, such as prostaglandins and peroxasalandine, which contribute to the production of inflammatory intermediators [18].

5.5. Immunomodulatory Activity

The immunomodulatory effect of different concentrations of M. vulgare aqueous extracts (100, 500, and 1000 mg/kg body weight) was evaluated as a cure agent in mice previously infected with Salmonella typhimurium and as a protective agent in mice infested with S. typhimurium [83]. According to these results, the lowest concentration of M. vulgare (100 mg/kg body weight) showed high immunomodulatory effect in the level of double positive T cells, interleukin (17AIL-17) and interferon-gamma (IFN-γ).

5.6. Sedative Activity

The potential to reduce morphine withdrawal signs in animals had been studied using aqueous and ethanolic extracts of M. vulgare in different doses (0.1, 0.5, 1.5, and 2.5 g/kg). It was concluded that all doses reduced the physical activity of mice. They also induced muscle relaxation [84].

5.7. Antidiabetic Activity

Marrubium vulgare has an ethnomedical record as an antidiabetic agent [85,86]. Certain efforts have been made in order to obtain scientific evidence supporting its traditional use in diabetes mellitus control [87]. Hellal et al. [88] performed in vitro screening for the α-glucosidase inhibitory activity of six Algerian traditional medicinal plant extracts where M. vulgare 80% ethanol extracts exerted a moderate effect (IC50 = 12.66 μg/mL). Moreover, a series of in vivo experiments were carried out on alloxan-induced diabetes during which the experimental animals were treated twice a day with aqueous extract of M. vulgare for 15 days [27]. Oral administration of 200 and 300 mg/kg body weight of M. vulgare aqueous extract induced significant dose-dependent antidiabetic and antihyperlipidemic effects. A dose of 100 mg/kg reduced blood glucose by 50%, whereas doses of 200 and 300 mg/kg showed more than 60% reduction of the same parameter. A decrease of total lipids, triglycerides, and cholesterol levels were observed in animals treated with M. vulgare when compared to the diabetic control group. Glibenclamide was used as a reference and showed similar effects, and the authors hypothesized that flavonoids and verbascoside derivatives present in examine extract caused the observed effects [27].

Chakir et al. [89] showed that the oral administration of M. vulgare methanolic extracts resulted in a significant lowering of blood glucose level, serum urea, uric acid, and creatinine, as well as a correction of lipid profiles when compared to streptozotocin-induced diabetic rats. These methanolic extracts significantly increased the glucose uptake of liver and skeletal muscles. Contrary to this, they reduced the glucose absorption in the everted rat jejunum. These results suggest that the effect of M. vulgare extract may be due to extrapancreatic mechanisms. This antidiabetic effect is an outcome of the modulation of glycogen synthesis and the inhibition of intestinal glucose absorption.

Another study [90] showed the effect of different M. vulgare extracts (methanol, water, and buthanol) on autoimmune diabetes mellitus induced by cyclosporine and streptozotocin. When compared to diabetic mice, the animals from the group treated with extracts of M. vulgare showed a decrease in blood glucose levels, pancreatic levels of interferon gamma (IFN-γ), and NO. M. vulgare extracts also caused a significant decrease in total cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and triglycerides. Additionally, the serum insulin levels were significantly increased after treatment with M. vulgare.

In addition, Alkofahi et al. [91] screened 21 plants grown in Jordan for their antihyperglycemic activity on Sprague–Dawley rats at 1 g/kg where M. vulgare extract showed a neutral effect on blood glucose levels.

The incidence of atherosclerosis and cardiovascular diseases increases in diabetes mellitus patients. Therefore, the effects of M. vulgare on the contractile reactivity of isolated aorta were analyzed in an experimental model of streptozotocin-induced diabetic rats after two months of oral administration of M. vulgare [92]. The results showed that serum glucose levels increased significantly in diabetic rats, while this increase was not observed in animals treated with M. vulgare. In addition, M. vulgare-treated rats showed a lower concentration of KCl and noradrenaline in comparison to the control group. Based on these results, it was concluded that the oral administration of M. vulgare during 2 months could attenuate the contractile responsiveness of the vascular system, which may prevent the development of hypertension in diabetic rats.

Although there is an evident antihyperglycemic effect of M. vulgare extract on induced diabetes in experimental animals, the duration of these studies were short, and also another model of type 2 diabetes studies would be interesting to elucidate the exact mechanisms of action of this plant. In addition, there has been one clinical trial that contradicted findings from animal studies. Namely, aqueous extract (infusion of dried M. vulgare leaves) was tested to evaluate a clinical effect in 22 type 2 diabetic patients that had poor response to conventional treatment. The results showed that infusion reduced glucose levels by only 0.64%, cholesterol by 4.16%, and triglycerides by 5.78% [93]. Finally, novel clinical trials are essential in order to confirm antidiabetic activity in humans as well as determine the right therapeutic protocol, potential adverse effects, and precautions.

5.8. Antihypertensive Activity

The water extract of M. vulgare is widely used as an antihypertensive treatment in folk medicine. Crude extracts of the aerial parts of M. vulgare show a potent in vitro inhibition of KCl-induced contraction of rat aorta. Bioguided fractionations, spectroscopic analysis, and chemical derivatization revealed furanic labdane diterpenes, marrubenol, and marrubiin as the most active compounds [33,37]. By analyzing the effects that 10-week-long treatment with amlodipine and M. vulgare water extract had on the systolic blood pressure, cardiovascular remodeling, and vascular relaxation in spontaneously hypertensive rats, it was observed that treatment with M. vulgare produced a decrease in systolic blood pressure. In addition, it had significant antihypertrophic effect in aorta and it improved acetylcholine (ACh)-induced relaxation of mesenteric artery. These results demonstrated that in addition to its antihypertensive effect, M. vulgare water extract improved the impaired endothelial function in spontaneously hypertensive rats [94].

5.9. Hypolipemic Activity

One study evaluated the hypocholesterolemic and hypotriglyceridemic activities of four M. vulgare herb extracts (petroleum ether, chloroform, ethyl acetate, and methanol) using Triton WR-1339-induced hyperlipidemia in mice. Extracts were applied using 0.1 and 0.25 LD50 concentrations. After 7 h and 24 h of treatment, the intragastric administration of all extracts caused a significant decrease of plasma total cholesterol; LDL cholesterol and triglyceride levels were also significantly lowered by all extracts. Additionally, more polar extracts (methanol and ethyl acetate) showed a significant ameliorative action on elevated atherogenic index (AI) and LDL/HDL-C ratios [95]. These findings coincide with recorded decreases in the total cholesterol and LDL cholesterol levels during antidiabetic studies, which was probably due to a stimulation of the insulin secretion [86].

Moreover, since metabolic syndrome as a cluster of conditions includes increased blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels, all of which are influenced by Marrbium vulgare herb extract, it would be useful to evaluate its possible usage as a part of nutrcaceuticals approach to this indication [96].

5.10. Gastroprotective Activity

In the model of ethanol-induced ulcers, a significant reduction in all analyzed parameters was observed when M. vulgare extract was applied [34]. The curative ratios were 49.31–74.31% for the groups treated with 50 and 100 mg/kg of M. vulgare extract. For indomethacin-induced ulcers, the percentages of ulcer inhibition were 50.32%, 66.24%, and 82.17% for the groups treated with 25, 50, and 100 mg/kg of M. vulgare. In both models, the marrubiin (25 mg/kg) produced a significant reduction in all parameters compared to the control group. There was also a significant increase in pH and mucus production in groups treated with M. vulgare extracts and marrubiin. The results demonstrated that the gastroprotective effect induced by these extracts and marrubiin is related to the activity of NO and endogenous sulfhydryls, which are important gastroprotective factors.

5.11. Antimicrobial Activity

The antibacterial potential of different M. vulgare extracts (ethyl acetate, diethyl ether, and 1-butanol) was tested on four strains of bacteria: Staphylococcus aureus, Escherichia coli, Proteus vulgaris, and Pseudomonas aeruginosa. The antibacterial activity of different fractions performed on solid agar medium showed little or no effect. This implies that the antibacterial activity proved with crude extract of M. vulgare was likely induced by synergistic action in chemical ingredients present in the extracts [97]. The methanolic extract of M. vulgare showed a significant antimicrobial activity against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, Proteus vulgaris, and Candida albicans [59].

Moreover, one study was undertaken to determine the antifungal activity of flavonoids (flavans and flavanols) extracted from the leaves of M. vulgare against two fungal strains; Aspergillus niger ATCC 16,404 and Candida albicans ATCC 10,231 using the solid medium diffusion method. The minimum inhibitory concentrations (MICs) obtained range between 6.25 and 100 μg/mL and led to experiencing strong antifungal inhibition, which often exceeded the effect of marketed antifungals (amphotericin, fluconazole, terbinafine, and econazole nitrate) that marked M. vulgare flavonoids as potentially powerful antifungal agents [98]. In addition, Rezgui et al. [68] concluded that M. vulgare and marrubiin can be used as antifungal agents for the treatment of skin dermatophyte infections. They examined the effect of acetone and methanol extracts, essential oil, and marrubin (all in two doses: 20 and 100 μg/mL) against the dermatophytes fungi Microsporum gypseum, Microsporum canis, Arthroderma cajetani, Trichophyton mentagrophytes, Trichophyton tonsurans, Epidermophyton floccosum, and against two fungi strains (Botrytis cinerea, Pythium ultimum).

M. vulgare essential oil has a significant effect on microorganisms, especially Gram+ bacteria with inhibition zones and MIC values in the range of 6.6–25.2 mm and 1120–2600 μg/mL, respectively, whereas Gram– bacteria exhibited higher resistance. When it comes to antifungal activity, among the four strains tested, Botrytis cinerea exhibited the strongest response to M. vulgare essential oil, with inhibition zones of 12.6 mm. However, Fusarium solani, Penicillium digitatum, and Aspergillus niger were less sensitive to this essential oil [77].

5.12. Wound Healing (Hemostatic)

The study of use of methanolic extract of M. vulgare in wound reparation demonstrated that this extract, which was rich in poliphenolic compounds (flavonoids and several phenylethanoid glycosides) and marrubiin (6.62%), showed antioxidant and wound-healing properties by promoting cell migration and the proliferation of fibrosis [23]. The assessment of hemostatic activity through the plasma recalcification method confirmed the surprising dose-dependent anticoagulant effect of aqueous extract of M. vulgare [26]. A positive linear correlation between the studied parameters, content of condensed tannins, and hemostatic activity was used to highlight the potent vasoconstriction property of these compounds.

5.13. Antiviral Activity

Acute and recurrent herpes simplex virus type 1 (HSV-1) infections remain an important problem due to the emergence of acyclovir resistant virus. As a result of that, the search for novel antiviral bioactive compounds from plants has intensified in recent years. The antiviral activity of methanol, hexane, and chloroform extract of M. vulgare showed antiviral activity with selectivity indices of 3.11, 2.8, and 1.28, respectively. This study revealed that the hexane fraction disrupts the early steps of cyclic replication, including HSV-1 attachment, in a dose-dependent manner [99].

5.14. Antiparasitic Activity

Toxoplasma gondii is an intracellular parasite that causes many symptoms, such as encephalitis and congenital disorders. Using MTT (3-(4,5-dimethylthiazol-2-yl)-2–5-diphenyltetrazolium bromide) cell-proliferation assay in vitro, it was concluded that M. vulgare could be very useful against this parasite [100].

5.15. Antiprotozoal Activity

M. vulgare essential oil and extracts (n-hexane, ethyl acetate, and methanol) have potent antiprotozoal activity against Trichomonas vaginalis. After 48 h of exposure, the essential oil with a minimal inhibitory concentration value of 291 μg/mL showed the highest antiprotozoal activity, followed by ethyl acetate (541 μg/mL), methanol (1000 μg/mL), and n-hexane (1500 μg/mL). According to the findings of this study, the compounds of M. vulgare have a significant effect on T. vaginalis [101].

5.16. Antiplasmodial Activity

The antiplasmodial activity of ethanolic extract of M. vulgare was evaluated in mice infected with chlorquine-sensitive Plasmodium berghei-berghei using curative, suppressive, and prophylactic experimental animal models. Preliminary phytochemical screening and intraperitoneal LD50 (50% lethal dose) estimation of the extract were carried out. In all doses tested, the extract produced significant curative and suppressive effects with minimal prophylactic effect. The extract also significantly prolonged the survival time of treated mice (up to 22 d), compared to the negative control group (11 d). The results of this study suggest that the ethanol extract of M. vulgare possesses curative and suppressive antiplasmodial activity in mice at all tested doses [102].

5.17. Veterinary Medicine

The anthelmintic activities of ethanolic and aqueous extract of M. vulgare were evaluated using the egg hatch assay and larval mortality assay. After a 24 h exposure period at a concentration of 50 mg/mL, the mortality rate was 45.8% for the aqueous extract and 51% for the ethanolic extract. These findings showed that M. vulgare extracts have potential anthelmintic effect on eggs and larvae of bovine strongyles parasites in vitro [103].

Bovine mastitis is the most serious diary problem in terms of economic losses to the dairy industry. With new generations of virulence and resistant bacteria, finding alternative treatments with medicinal plants to control these pathogenic strains is very popular. Among others, the ethanol extract of M. vulgare shows good antibacterial activity against methicillin-resistant staphylococci and multi-resistant Escherichia coli strains isolated from animals with mastitis manifestation [104].

5.18. Use as Natural Pesticides

In Spain, M. vulgare has been popularly used on chicken farms to prevent lice and frequent scratching of animals, which intensified its planting on farms [12]. Moreover, a plant extract of M. vulgare was tested against fourth instar larvae of the mosquito Culex pipiens. The obtained results indicated a sensitivity of C. pipiens larvae that was even higher when the exposure time of larvae to the insecticide is extended. The greatest mortality rate (94%) was achieved with 900 mg/L and a 72 h exposure to M. vulgare extract, whereas a 59% mortality rate was achieved with 900 mg/L and a 72 h exposure period. These results may provide an opportunity to develop alternatives to environmentally hazardous chemicals using some readily available, affordable plants which are mostly harmless to different living organisms [105]. Furthermore, the volatile oil of M. vulgare has a remarkable toxicity on the snails of both Schistosoma mansoni and S. haematobium species [106]. In addition, M. vulgare leaf extract and rizosphere soil extract significantly influence the seed germination and seedling growth of Sinapis arvensis and Latuca sativa in laboratory conditions. However, the allelopatic effects depend on target species. These extracts can be used as an important source of natural herbicides to control weeds in crop fields [29].

6. Conclusions

M. vulgare produce structurally highly diverse groups of secondary metabolites, thus representing the valuable source of bioactive compounds and preparations with health-promoting effects: antioxidant, hepatoprotective, antiproliferative, anti-inflammatory, antidiabetic, and antimicrobial being the most investigated. Although these effects of M. vulgare extracts, essential oil, marrubiin, flavan and flavonol type of flavonoids, and phenylethyl esters were studied, the pharmacokinetics of these compounds and the concentrations of extracts, essential oil, and isolated compounds needed for the pharmacological effect have yet to be established. White horehound is a part of traditional medicine systems worldwide; it is generally recognized as safe, but well designed clinical trials are needed in order to shift from traditional to a well-established use of M. vulgare herb preparations for the prevention and treatment of various ailments.

7, References

1. Knoss W. Marrubium vulgare (White Horehound): In vitro culture, and the production of diterpene marrubiin and other secondary metabolites. In: Biotechnology in Agriculture and ForestryBajaj Y.P.S., editor. Medicinal and Aromatic Plants XI. Volume 43. Springer; Berlin/Heidelberg, Germany: 1999. pp. 274–289. [CrossRef] [Google Scholar]

2. EMA—European Medicines Agency, Committee on Herbal Medicinal Products (HMPC) Community Herbal Monograph on Marrubium vulgare L., herba. HMPC; London, UK: 2013. EMA/HMPC/604271/2012. [Google Scholar]

3. Lodhi S., Vadnere G.P., Sharma V.K., Usman M.R. Marrubium vulgare L.: A review on phytochemical and pharmacological aspects. J. Intercult. Ethnopharmacol. 2017;6:429–452. doi: 10.5455/jice.20170713060840. [CrossRef] [Google Scholar]

4. Ahvazi M., Balali G.R., Jamzad Z., Saeidi H. A taxonomical, morphological and pharmacological review of Marrubium vulgare L., an old medicinal plant in Iran. J. Med. Plants. 2018;17:7–24. [Google Scholar]

5. Yabrir B. Essential oil of Marrubium vulgare: Chemical composition and biological activities. A review. Nat. Prod. Sci. 2019;25:81–91. doi: 10.20307/nps.2019.25.2.81. [CrossRef] [Google Scholar]

6. Dmitruk M., Haratym W. Morphological differentiation of non-glandular and glandular trichomes on Marrubium vulgare L. Mod. Phytomorphol. 2014;6:85. doi: 10.5281/zenodo.160450. [CrossRef] [Google Scholar]

7. Zawislak G. Cropping evaluation of white horehound (Marrubium vulgare L.), grown from sowing and seedling. Herba Pol. 2009;55:63–68. [Google Scholar]

8. El-Leithy A.S., El-Hanafy S.H., Omer E.A., El-Sayed A.A.A. Effect of nitrogen and potassium biofertilization on growth, yield and essential oil production of white horehound, Marrubium vulgare L. Plant. J. Hortic. Sci. Ornam. Plants. 2013;5:46–59. doi: 10.5829/idosi.jhsop.2013.5.1.272. [CrossRef] [Google Scholar]

9. Bergeron C., Charbonneau J., Desroches B., Gosselin A. Influence of supplemental lighting and irrigation on mineral composition, growth and premarrubin content of horehound, Marrubium vulgare L. J. Herbs Species Med. Plants. 1995;3:3–15. doi: 10.1300/J044v03n01_02. [CrossRef] [Google Scholar]

10. Weiss J., Ainsworth N., Faithfull I. Horehound, Marrubium vulgare. Best Practice Management Guide for Environmental Weeds. CRC for Weed Management Systems; Orange, Australia: 2008. [Google Scholar]

11. Amri B., Kaab S.B., Gouia H., Martino E., Collina S., Kaab L.B.B. Copper-induced changes in nutrient uptake, enzymatic and non-enzymatic antioxidant systems in horehound (Marrubium vulgare L.) Bot. Sci. 2017;95:565–575. doi: 10.17129/botsci.778. [CrossRef] [Google Scholar]

12. Rezgui M., Majdoub N., Ben-Kaab S., Marzouk B., Gouia H., Araujo M.E.M., Ben-Kaab L.B. How salt stress represses the biosynthesis of marrubiin and disturbs the antioxidant activity of Marrubium vulgare L. Pol. J. Environ. Stud. 2017;26:267–277. doi: 10.15244/pjoes/64792. [CrossRef] [Google Scholar]

13. Ardic M., Sezer O., Koyuncu O., Yaylaci K., Erkara I.P. Identification of the effects of boron stress on Marrubium vulgare L. (Lamiaceae) Int. J. Environ. Res. Technol. 2018;1:17–19. [Google Scholar]

14. Mittal V., Nanda A. The pharmacognostical evaluation of the Marrubium vulgare Linn collected from the Pulwama district of Jammu and Kashmir State of India. J. Chem. Pharm. Res. 2016;8:7–15. [Google Scholar]

15. Amessis-Ouchemoukh N., Abu-Reidah I.M., Quirantes-Piné R., Madani K., Segura-Carretero A. Phytochemical profiling, in vitro evaluation of total phenolic contents and antioxidant properties of Marrubium vulgare (horehound) leaves of plants growing in Algeria. Ind. Crops Prod. 2014;61:120–129. doi: 10.1016/j.indcrop.2014.06.049. [CrossRef] [Google Scholar]

16. Ahmed B., Masoodi M.H., Siddique A.H., Khan S. A new monoterpene acid from Marrubium vulgare with potential antihepatotoxic activity. Nat. Prod. Res. 2010;24:1671–1680. doi: 10.1080/14786410802280976. [PubMed] [CrossRef] [Google Scholar]

17. Verma A., Masoodi M., Ahmed B. Lead findings from whole plant of Marrubium vulgare L. with hepatoprotective potentials through in silico methods. Asian Pac. J. Trop. Biomed. 2012;2:S1308–S1311. doi: 10.1016/S2221-1691(12)60406-7. [CrossRef] [Google Scholar]

18. Neamah S.I., Sarhan I.A., Al-Shayea O.N. Extraction and evaluation of the anti-inflammatory activity of six compounds of Marrubium vulgare L. Biosci. Res. 2018;15:2393–2400. [Google Scholar]

19. Knoss W., Zapp J. Accumulation of furanic labdane diterpenes in Marrubium vulgare and Leonorus cardiaca. Planta Med. 1998;64:357–361. doi: 10.1055/s-2006-957451. [PubMed] [CrossRef] [Google Scholar]

20. Shaheen F., Rasool S., Shah Z.A., Soomro S., Jabeen A., Mesaik M.A., Choudhary M.I. Chemical constituents of Marrubium vulgare as potential inhibitors of nitric oxide and respiratory burst. Nat. Prod. Commun. 2014;9:903–906. doi: 10.1177/1934578X1400900705. [PubMed] [CrossRef] [Google Scholar]

21. Piozzi F., Bruno M., Rosselli S., Maggio A. The diterpenoids of the genus Marrubium (Lamiaceae) Nat. Prod. Commun. 2006;1:585–592. doi: 10.1177/1934578X0600100713. [CrossRef] [Google Scholar]

22. Paunovic V., Kostic M., Djordjevic S., Zugic A., Djalinac N., Gasic U., Trajkovic V., Harhaji-Trajkovic J. Marrubium vulgare ethanolic extract induces proliferation block, apoptosis and cytoprotective autophagy in cancer cells in vitro. Cell. Mol. Biol. 2016;62:108–114. [PubMed] [Google Scholar]

23. Amri B., Martino E., Vitulo F., Corana F., Kaab L.B.B., Rui M., Rossi D., Mori M., Rossi S., Collina S. Marrubium vulgare L. leaves extract: Phytochemical composition, antioxidant and wound healing properties. Molecules. 2017;22:1851. doi: 10.3390/molecules22111851. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

24. Masoodi M., Ali Z., Liang S., Yin H., Wang W., Khan I.A. Labdane diterpenoids from Marrubium vulgare. Phytochem. Lett. 2015;13:275–279. doi: 10.1016/j.phytol.2015.07.005. [CrossRef] [Google Scholar]

25. Yousefi K., Hamedeyazdan S., Torbati M., Fathiazad F. Chromatographic fingerprint analysis of marrubiin in Marrubium vulgare L. via HPTLC technique. Adv. Pharm. Bull. 2016;6:131–136. doi: 10.15171/apb.2016.019. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

26. Ghedadba N., Hambaba L., Fercha N., Houas B., Abdessemed S., Mokhtar S.M.O. Assessment of hemostatic activity of the aqueous extract of leaves of Marrubium vulgare L., a Mediterranean Lamiaceae Algeria. Int. J. Health Sci. 2016;2:253–258. doi: 10.20319/lijhls.2016.s21.253258. [CrossRef] [Google Scholar]

27. Boudjelal A., Henchiri C., Siracusa L., Sari M., Ruberto G. Compositional analysis and in vivo anti-diabetic activity of wild Algerian Marrubium vulgare L. infusion. Fitoterapia. 2012;83:286–292. doi: 10.1016/j.fitote.2011.11.005. [PubMed] [CrossRef] [Google Scholar]

28. Salaj N., Barjaktarović J., Kladar N., Gavarić N., Božin B. Biomedical potential of horehound extract (Marrubium vulgare, Lamiaceae) Med. Pregl. 2018;71:21–26. doi: 10.2298/MPNS1802021S. [CrossRef] [Google Scholar]

29. Dallali S., Rouz S., Aichi H., Ben Hassine H. Phenolic content and allelopathic potential of leaves and rizosphere soil aqueous extracts of white horehound (Maribum vulgare L.) J. New Sci. Agric. Biotechnol. 2017;39:2106–2120. [Google Scholar]

30. Okur M.E., Karakas N., Karadag A.E., Yilmaz R., Demirci F. In vitro cytotoxicity evaluation of Marrubium vulgare L. methanol extract. J. Res. Pharm. 2019;23:711–718. doi: 10.12991/jrp.2019.180. [CrossRef] [Google Scholar]

31. Ghedadba N., Hambaba L., Bousselsela H., Hachemi M., Drid A., Abd-Essmad A., Oueld-Mokhtar S.M. Evaluation of in vitro antioxidant and in vivo anti-inflammatory potential of white horehound (Marrubium vulgare L.) leaves. Int. J. Pharm. Sci. Rev. Res. 2016;41:252–259. [Google Scholar]

32. Gavarić A., Vladić J., Ambrus R., Jokić S., Szabo-Revesz P., Tomić M., Blažić M., Vidović S. Spray drying of a subcritical extract using Marrubium vulgare as a method of choice for obtaining high quality powder. Pharmaceutics. 2019;11:523. doi: 10.3390/pharmaceutics11100523. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

33. El Bardai S., Wibo M., Hamaide M.C., Lyoussi B., Quetin-Leclercq J., Morel N. Characterisation of marubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker. Br. J. Pharmacol. 2003;140:1211–1216. doi: 10.1038/sj.bjp.0705561. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

34. Oliveira A.P., Santin J.R., Lemos M., Junior L.C.K., Couto A.G., Bittencourt C.M.S., Filho V.C., Andrade S.F. Gastroprotective activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare L. (Lamiaceae) J. Pharm. Pharmacol. 2011;63:1230–1237. doi: 10.1111/j.2042-7158.2011.01321.x. [PubMed] [CrossRef] [Google Scholar]

35. Popoola O.K., Elbagory A.M., Ameer F., Hussein A. Marrubiin. Molecules. 2013;18:9049–9060. doi: 10.3390/molecules18089049. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

36. Stulzer H.K., Tagliari M.P., Zampirolo J.A., Cechinel-Filho V., Schlemper V. Antioedematogenic effect of marrubiin obtained from Marrubium vulgare. J. Ethnopharmacol. 2006;108:379–384. doi: 10.1016/j.jep.2006.05.023. [PubMed] [CrossRef] [Google Scholar]

37. El Bardai S.E., Morel N., Wibo M., Fabre N., Llabres G., Lyoussi B., Quetin-Leclercq I. The vasorelaxant activity of marrubenol and marrubiin from Marrubium vulgare. Planta Med. 2003;69:75–77. doi: 10.1055/s-2003-37042. [PubMed] [CrossRef] [Google Scholar]

38. Dewick M.P. Medicinal Natural Products: A Biosynthetic Approach. 3rd ed. John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2009. [Google Scholar]

39. Boulila A., Sanaa A., Salem I.B., Rokbeni N., M’rabet Y., Hosni K., Fernandez X. Antioxidant properties and phenolic variation in wild populations of Marrubium vulgare L. (Lamiaceae) Ind. Crops Prod. 2015;76:616–622. doi: 10.1016/j.indcrop.2015.07.069. [CrossRef] [Google Scholar]

40. Sahpaz S., Garbacki N., Tits M., Bailleul F. Isolation and pharmacological activity of phenylpropanoid esters from Marrubium vulgare. J. Ethnopharmacol. 2002;79:389–392. doi: 10.1016/S0378-8741(01)00415-9. [PubMed] [CrossRef] [Google Scholar]

41. Pukalskas A., Venskutonis P.R., Salido S., de Waard P., van Beek T.A. Isolation, identification and activity of natural antioxidants from horehound (Marrubium vulgare L.) cultivated in Lithuania. Food Chem. 2012;130:695–701. doi: 10.1016/j.foodchem.2011.07.112. [CrossRef] [Google Scholar]

42. Kurbatova N.V., Muzychkina R.A., Mukhitdinov N.M., Parshina G.N. Comparative phytochemical investigation of the composition and content of biologically active substances in Marrubium vulgare and M. alternidens. Chem. Nat. Compd. 2003;39:501–502. doi: 10.1023/B:CONC.0000011128.64886.f4. [CrossRef] [Google Scholar]

43. Nawal H.M., Atta E.M. Cytotoxic and antioxidant activity of Marrubium vulgare and flavonoid constituents; Proceedings of the 2nd International Conference on Chemical, Environmental and Biological Sciences; Dubai, UAE. 17–18 March 2013. [Google Scholar]

44. Nawwar M.A.M., El-Mousallamy A.M.D., Barakat H.H., Buddrus J., Linscheid M. Flavonoid lactates from leaves of Marrubium vulgare. Phytochemistry. 1989;28:3201–3206. doi: 10.1016/0031-9422(89)80307-3. [CrossRef] [Google Scholar]

45. Alkhatib R., Joha S., Cheok M., Roumiy V., Idziorek T., Preudhomme C., Quesnel B., Sahpaz S., Bailleul F., Hennebelle T. Activity of ladanein on leukemia cell lines and its occurrence in Marrubium vulgare. Planta Med. 2010;76:86–87. doi: 10.1055/s-0029-1185972. [PubMed] [CrossRef] [Google Scholar]

46. Karunanithi P.S., Dhanlta P., Addison J.B., Tong S., Fiehn O., Zerbe P. Functional characterization of the cytochrome P450 monooxygenase CYP71AU87 indicates a role in marrubiin byosynthesis in the medicinal plant Marrubium vulgare. BMC Plant Biol. 2019;19:114. doi: 10.1186/s12870-019-1702-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

47. WHO Organization . Quality Control Methods for Herbal Materials. World Health Organization; Geneva, Switzerland: 2011. [Google Scholar]

48. Bandaranayake W.M. Quality control, screening, toxicity, and regulation of herbal drugs. In: Farrukh I.A., Owais M., editors. Modern Phytomedicine: Turning Medicinal Plants into Drugs. Wiley-VCH Verlag GmbH & Co. KGaA; Weinheim, Germany: 2006. pp. 25–57. [CrossRef] [Google Scholar]

49. Bahammou Y., Tagnamas Z., Lamharrar A., Idlimam A. Thin-layer solar drying characteristics of Moroccan horehound leaves (Marrubium vulgare L.) under natural and forced convection solar drying. Sol. Energy. 2019;188:958–969. doi: 10.1016/j.solener.2019.07.003. [CrossRef] [Google Scholar]

50. Rezazi S., Hanini S., Si-Moussa C., Abdelmalek S. Modeling and optimization of the operating conditions of Marrubium vulgare L. essential oil extraction process: Kinetic parameters estimation through genetic algorithms. J. Essent. Oil Bear. Plants. 2016;19:843–853. doi: 10.1080/0972060X.2016.1191973. [CrossRef] [Google Scholar]

51. Martino E., Volpe S.D., Cavalloro V., Amri B., Kaab L.B.B., Marrubini G., Rossi D., Collina S. The use of a microwave-assisted solvent extraction coupled with HPLC-UV/PAD to assess the quality of Marrubium vulgare L. (white horehound) herbal raw material. Phytochem. Anal. 2019;30:1–8. doi: 10.1002/pca.2820. [PubMed] [CrossRef] [Google Scholar]

52. Rodrigues C.A., Savi A.O.S., Schlemper V., Reynaud F., Cechinel-Filho V. An improved extraction of marrubiin from Marrubium vulgare. Chromatographia. 1998;47:449–450. doi: 10.1007/BF02466478. [CrossRef] [Google Scholar]

53. Bouterfas K., Mehdadi Z., Benmansour D., Khaled M.B., Bouterfas M., Latreche A. Optimization of extraction conditions of some phenolic compounds from white horehound (Marrubium vulgare L.) leaves. Int. J. Org. Chem. 2014;4:292–308. doi: 10.4236/ijoc.2014.45032. [CrossRef] [Google Scholar]

54. Rezazi S., Abdelmalek S., Hanini S. Kinetic study and optimization of extraction process condition. Energy Procedia. 2017;139:98–104. doi: 10.1016/j.egypro.2017.11.180. [CrossRef] [Google Scholar]

55. Miloudi K., Hamimed A., Benmimoun Y., Bellebna Y., Taibi A., Tilmatine A. Intensification of essential oil extraction of the Marrubium vulgare using pulsed electric field. J. Essent. Oil Bear. Plants. 2018;21:811–824. doi: 10.1080/0972060X.2018.1484820. [CrossRef] [Google Scholar]

56. Steinmetz E.F. Materia Medica Vegetabilis. Published by Author; Amsterdam, The Netherlands: 1954. [Google Scholar]

57. Thomas D.L., Thomas L.B. Kentucky Superstitions. Princeton University Press; Princeton, NJ, USA: 1920. [Google Scholar]

58. Bisset N.G. In: Herbal Drugs and Phytopharmaceuticals. Wichtl M., editor. CRC Press; Boca Raton, FL, USA: 2001. [Google Scholar]

59. Kanyonga P.M., Faouzi M.A., Maddah B., Mpona M., Essassi E.M., Cherrah Y. Assessment of methanolic extract of Marrubium vulgare for anti-inflammatory, analgesic and anti-microbiologic activities. J. Chem. Pharm. Res. 2011;3:199–204. [Google Scholar]

60. Akther N., Shawl A., Sultana S., Chandan B., Akhter M. Hepatoprotective activity of Marrubium vulgare against paracetamol induced toxicity. J. Pharm. Res. 2013;7:565–570. doi: 10.1016/j.jopr.2013.06.023. [CrossRef] [Google Scholar]

61. Commission E.P. European Pharmacopoeia 8th Edition: Supplement 8.0. Council of Europe; Strasbourg, France: 2014. [Google Scholar]

62. Kadri A., Zarai Z., Békir A., Gharsallah N., Damak M., Gdoura R. Chemical composition and antioxidant activity of Marrubium vulgare L. essential oil from Tunisia. Afr. J. Biotechnol. 2011;10:3908–3914. [Google Scholar]

63. Aouni R., Ben Attia M., Jaafoura M.H., Bibi-Derbel A., Haouari M. Effects of the hydro-ethanolic extract of Marrubium vulgare in female rats. Asian Pac. J. Trop. Med. 2017;10:160–164. doi: 10.1016/j.apjtm.2017.01.010. [PubMed] [CrossRef] [Google Scholar]

64. Mokhtari M., Ebrahimpoor M.R., Harfsheno S. The effects of alcoholic extract of Marrubum vulgare on hormonal parameters in female rat model of polycystic ovarian syndrome. Med. Sci. 2014;24:74–80. [Google Scholar]

65. Kolangi F., Memariani Z., Bozorgi M., Mozaffarpur S.A., Mirzapour M. Herbs with Potential Nephrotoxic Effects According to the Traditional Persian Medicine: Review and Assessment of Scientific Evidence. Curr. Drug Metab. 2018;19:628–637. doi: 10.2174/1389200219666180404095849. [PubMed] [CrossRef] [Google Scholar]

66. Mbah C.J., Orabueze I., Okorie N.H. Antioxidants properties of natural and synthetic chemical compounds: Therapeutic effects on biological system. Acta Sci. Pharm. Sci. 2019;3:28–42. doi: 10.31080/ASPS.2019.03.0273. [CrossRef] [Google Scholar]

67. Abadi A., Hassani A. Essential oil composition and antioxidant activity of Marrubium vulgare L. growing wild in Eastern Algeria. Int. Lett. Chem. Phys. Astron. 2013;9:17–24. doi: 10.18052/www.scipress.com/ILCPA.14.17. [CrossRef] [Google Scholar]

68. Rezgui M., Majdoub N., Mabrouk B., Baldisserotto A., Bino A., Ben Kaab L.B., Manfredini S. Antioxidant and Antifungal Activities of Marrubiin, Extracts and Essential Oil from Marrubium vulgare L. against Pathogenic Dermatophyte Strains. J. Mycol. Med. 2020;30:100927. doi: 10.1016/j.mycmed.2020.100927. [PubMed] [CrossRef] [Google Scholar]

69. Djeridane A., Yousfi M., Brunel J.M., Stocker P. Isolation and characterization of a new steroid derivative as a powerful antioxidant from Cleome arabica in screening the in vitro antioxidant capacity of 18 Algerian medicinal plants. Food Chem. Toxicol. 2010;48:2599–2606. doi: 10.1016/j.fct.2010.06.028. [PubMed] [CrossRef] [Google Scholar]

70. Weel K.G.C., Venskutonis P.R., Pukalskas A., Gruzdiene D., Linssen J.P.H. Antioxidant activity of horehound (Marrubium vulgare L.) grown in Lithuania. Lipid. 1999;101:395–400. doi: 10.1002/(SICI)1521-4133(199910)101:10<395::AID-LIPI395>3.0.CO;2-L. [CrossRef] [Google Scholar]

71. Bouterfas K., Mehdadi Z., Elaoufi M.M., Latreche A., Benchiha W. Antioxidant activity and total phenolic and flavonoids content variations of leaves extracts of white Horehound (Marrubium vulgare Linné) from three geographical origins. Ann. Pharm. Fr. 2016;74:453–462. doi: 10.1016/j.pharma.2016.07.002. [PubMed] [CrossRef] [Google Scholar]

72. Ibrahim F.M., Ibrahim A.Y., Omer E.A. Potential effect of Marrubium vulgare L. extracts on CCl4 model induced hepatotoxicity in albino mice. World J. Pharm. Sci. 2014;2:1664–1670. [Google Scholar]

73. El-Hallous E.I., Alsanie W.F., Ismail I.A., Dessoky E.S. Utilization of Marrubium vulgare extract as a therapeutic to hepatic damage induced by carbon tetrachloride in rats. Int. J. Pharm. Res. Allied Sci. 2018;7:168–178. [Google Scholar]

74. Elberry A.A., Harraz F.M., Ghareib S.A., Nagy A.A., Gabr S.A., Suliaman M.I., Abdel-Sattar E. Antixepatoxic effect of Marrubium vulgare and Withania somnifera extracts on carbon tetrachloride-induced hepatotoxicity in rats. J. Basic Clin. Pharm. 2010;1:247–254. [PMC free article] [PubMed] [Google Scholar]

75. Bourhia M., Abdelaziz Shahat A., Mohammed Almarfadi O., Ali Naser F., Mostafa Abdelmageed W., Ait Haj Said A., El Gueddari F., Naamane A., Benbacer L., Khlil N. Ethnopharmacological survey of herbal remedies used for the treatment of cancer in the greater Casablanca-Morocco. Evid. Based Complement. Altern. Med. 2019;10:1613457. doi: 10.1155/2019/1613457. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

76. Villanueva Rodriguez J., Martín Esteban J. An Insight into a Blockbuster Phytomedicine; Marrubium vulgare L. Herb. More of a Myth than a Reality? Phytother. Res. 2016;30:1551–1558. doi: 10.1002/ptr.5661. [PubMed] [CrossRef] [Google Scholar]

77. Zarai Z., Kadri A., Chobba I.B., Mansour R.B., Bekir A., Mejdoub H., Gharsallah N. The in-vitro evaluation of antibacterial, antifungal and cytotoxic properties of Marrubium vulgare L. essential oil grown in Tunisia. Lipids Health Dis. 2011;10:161. doi: 10.1186/1476-511X-10-161. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

78. Tlili H., Hanen N., Ben Arfa A., Neffati M., Boubakri A., Buonocore D., Dossena M., Verri M., Doria E. Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia. PLoS ONE. 2019;14:e0213049. doi: 10.1371/journal.pone.0213049. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

79. Kozyra M., Korga A., Ostrowska M., Humeniuk E., Adamczuk G., Gieroba R., Makuch-Kocka A., Dudka J. Cytotoxic Activity of Methanolic Fractions of Different Marrubium spp. against Melanoma Cells Is Independent of Antioxidant Activity and Total Phenolic Content. FEBS Open Bio. 2020;10:86–95. doi: 10.1002/2211-5463.12755. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

80. Shawky E. Prediction of Potential Cancer-Related Molecular Targets of North African Plants Constituents Using Network Pharmacology-Based Analysis. J. Ethnopharmacol. 2019;238:111826. doi: 10.1016/j.jep.2019.111826. [PubMed] [CrossRef] [Google Scholar]

81. Rameshrad M., Yousefi K., Fathiazad F., Soraya H., Hamedeyazdan S., Khorrami A., Maleki-Dizaji N., Garjani A. A methanolic extract of Marrubium vulgare L. suppresses inflammatory responses in isoproterenol induced myocardial infarction in rat. Res. Pharm. Sci. 2012;7:S959. [Google Scholar]

82. Yousefi K., Fathiazad F., Soraya H., Raameshrad M., Maleki-Dizaji N., Garjani A. Marrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in rats. BioImpacts. 2014;4:21–27. doi: 10.5681/bi.2014.001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

83. Ajedi A.S.S., Widodo N., Widyarti S., Rifai M. Immunomodulatory effect of Moringa oleifera and Marrubium vulgare leaf aqueous extracts in BALB/C mice infected with Salmonella typhimurium; Proceedings of the 144th the IRES International Conference; Bali, Indonesia. 30–31 October 2018. [Google Scholar]

84. Hosseinzadeh H., Ziaee T., Ahi A. Effect of Marrubium vulgare L. aerial parts aqueous and ethanolic extracts on morphine withdrawal syndrome in mice. Pharmacologyonline. 2007;3:422–427. [Google Scholar]

85. Barkaoui M., Katiri A., Boubaker H., Msanda F. Ethnobotanical Survey of Medicinal Plants Used in the Traditional Treatment of Diabetes in Chtouka Ait Baha and Tiznit (Western Anti-Atlas), Morocco. J. Ethnopharmacol. 2017;98:338–350. doi: 10.1016/j.jep.2017.01.023. [PubMed] [CrossRef] [Google Scholar]

86. Hamza N., Berke B., Umar A., Cheze C., Gin H., Moore N. A review of Algerian medicinal plants used in the treatment of diabetes. J. Ethnopharmacol. 2019;238:111841. doi: 10.1016/j.jep.2019.111841. [PubMed] [CrossRef] [Google Scholar]

87. Villanueva J.R., Esteban J.M., Villanueva L.R. A reassessment of the Marrubium vulgare L. herb’s potential role in diabetes mellitus type 2: First results guide in investigation toward new horizons. Medicines. 2017;4:57. doi: 10.3390/medicines4030057. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

88. Hellal K., Maulidiani M., Ismail I.S., Tan C.P., Abas F. Antioxidant, α-Glucosidase, and Nitric Oxide Inhibitory Activities of Six Algerian Traditional Medicinal Plant Extracts and 1 H-NMR-Based Metabolomics Study of the Active Extract. Molecules. 2020;25:1247. doi: 10.3390/molecules25051247. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

89. Chakir A.R.S., Elbadaoui K., Alaoui T. Antidiabetic activities of methanolic extracts of Marrubium vulgare leaves in rats. Int. J. Pharm. Phytopharm. Res. 2015;4:258–263. [Google Scholar]

90. Elmhdwi M.F. Hypoglycemic effects of Marrubium vulgare (Rubia) in experimentally induced autoimmune diabetes mellitus. Int. Res. J. Biochem. Bioinform. 2014;44:42–54. [Google Scholar]

91. Alkofahi A.S., Abdul-Razzak K.K., Alyoubi K.H., Khabour O.F. Screening of the Anti-hyperglycemic Activity of Some Medicinal Plants of Jordan. Pak. J. Pharm Sci. 2017;30:907–912. [PubMed] [Google Scholar]

92. Dehkordi F.R., Roghani M., Baluchnejadmojarad T. The effect of Marrubium vulgare on contractile reactivity of aorta in diabetic rats. ARYA Atheroscler. J. 2012;7:1–4. [Google Scholar]

93. Herrera-Arellano A., Aguilar-Santamaria L., Garcia-Hernandez B., Nicasio-Torres P.J.T. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine. 2004;11:561–566. doi: 10.1016/j.phymed.2004.01.006. [PubMed] [CrossRef] [Google Scholar]

94. El Bardai S.E., Lyoussi B., Wibo M., Morel N. Comparative study of the antihypertensive activity of Marrubium vulgare and of the dihydropyridine calcium antagonist amlodipine in spontaneously hypertensive rat. Clin. Exp. Hypertens. 2004;26:465–474. doi: 10.1081/CEH-200031818. [PubMed] [CrossRef] [Google Scholar]

95. Ibrahim A.Y., Hendawy S.F., Elsayed A.A.A., Omer E.A. Evaluation of Hypolipidemic Marrubium Vulgare Effect in Triton WR-1339-induced Hyperlipidemia in Mice. Asian Pac. J. Trop. Med. 2016;9:453–459. doi: 10.1016/j.apjtm.2016.03.038. [PubMed] [CrossRef] [Google Scholar]

96. Sirtori C.R., Pavanello C., Calabresi L., Ruscica M. Nutraceutical Approaches to Metabolic Syndrome. Ann. Med. 2017;49:678–697. doi: 10.1080/07853890.2017.1366042. [PubMed] [CrossRef] [Google Scholar]

97. Kahlouche-Riachi F., Djerrou Z., Ghoribi L., Djaalab I., Mansour-Djaalab H., Bensari C., Hamdi-Pacha Y. Chemical characterization and antibacterial activity of phases obtained from extracts of Artemisia herba alba, Marrubium vulgare and Pinus pinaster. Int. J. Pharmacogn. Phytochem. Res. 2015;7:270–274. [Google Scholar]

98. Bouterfas K., Mehdadi Z., Aouad L., Elaoufi M.M., Khaled M.B., Latreche A., Benchiha W. Does the sampling locality influence on the antifungal activity of the flavonoids of Marrubium vulgare against Aspergillus niger and Candida albicans? J. Mycol. Med. 2016;26:201–211. doi: 10.1016/j.mycmed.2016.02.019. [PubMed] [CrossRef] [Google Scholar]

99. Fayyad A.S.F., Ibrahim N., Yaakob W.A. Phytochemical screening and antiviral activity of Marrubium vulgare. Malays. J. Microbiol. 2014;10:106–111. [Google Scholar]

100. Bahadory E.S., Asl A.D., Mosavipoor S.S., Ghaffari A.D., Namroodi S., Novin S.G. The therapeutic effect of Marrubium vulgare, Salvia officinalis and Lippia citrodora in killing of Toxoplasma gondii tachyzoite and evaluation by MTT assay. Med. J. Tabriz Univ. Med. Sci. Health Serv. 2018;39:44–50. [Google Scholar]

101. Akbari Z., Dastan D., Maghsood A.H., Fallah M., Matini M. Investigation of in vitro efficacy of Marrubium vulgare L. essential oil and extracts against Trichomonas vaginalis. Zahedan J. Res. Med. Sci. 2018;20:e67003. doi: 10.5812/zjrms.67003. [CrossRef] [Google Scholar]

102. Abdussalam U.S., Aliyu M., Maje I.M. In vivo antiplasmodial activity of ethanol leaf extract of Marrubium vulgare L. (Lamiaceae) in Plasmodium berghei-berghei infected mice. Trop. J. Nat. Prod. Res. 2018;2:132–1135. doi: 10.26538/tjnpr/v2i3.6. [CrossRef] [Google Scholar]

103. Moussouni L., Benhanifia M., Ayad A. In vitro anthelmintic effects of aqueous and ethanolic extracts of Marrubium vulgare leaves against bovine digestive strongyles. Turkiye Parazitol. Derg. 2018;42:262–267. doi: 10.5152/tpd.2018.5972. [PubMed] [CrossRef] [Google Scholar]

104. Saidi R., Mimoune N., Baazizi R., Benaissa M.H., Khelef D., Kaidi R. A study of ethno-veterinary medicinal plants and in vitro antimicrobial activities against bovine mastitis isolated bacterial pathogens in Algeria. Bull. UASVM Vet. Med. 2019;76:154–161. doi: 10.15835/buasvmcn-vm:2019.0010. [CrossRef] [Google Scholar]

105. Aouati A., Berchi S. Larvicidal effect of Marrubium vulgare on Culex pipiens in eastern Algeria. Energy Procedia. 2015;74:1026–1031. doi: 10.1016/j.egypro.2015.07.739. [CrossRef] [Google Scholar]

106. Saleh M.M., Glombitza K.W. Volatile oil of Marrubium vulgare and its anti-schistosomal activity. Planta Med. 1989;55:105–106. doi: 10.1055/s-2006-961873. [CrossRef] [Google Scholar